Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. Revenue 2023–2025
Connect Biopharma Holdings Ltd. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Connect Biopharma Holdings Ltd. revenue for the quarter ending March 31, 2026 was 169000.
- Connect Biopharma Holdings Ltd. revenue for the twelve months ending March 31, 2026 was 233000.
- Connect Biopharma Holdings Ltd. annual revenue for 2025 was 64000, a 99.75% decrease from 2024.
- Connect Biopharma Holdings Ltd. annual revenue for 2024 was 26.0 M.
- Connect Biopharma Holdings Ltd. annual revenue for 2023 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Connect Biopharma Holdings Ltd. Market Cap — FAQ
Connect Biopharma Holdings Ltd. (CNTB) market cap over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNTB's market cap history?
The chart and table above show Connect Biopharma Holdings Ltd.'s market cap by year and by quarter, including the growth rate.